Johanna I. Lutter

449 total citations
23 papers, 234 citations indexed

About

Johanna I. Lutter is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Johanna I. Lutter has authored 23 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Johanna I. Lutter's work include Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Asthma and respiratory diseases (10 papers) and Respiratory Support and Mechanisms (6 papers). Johanna I. Lutter is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Asthma and respiratory diseases (10 papers) and Respiratory Support and Mechanisms (6 papers). Johanna I. Lutter collaborates with scholars based in Germany, Netherlands and Austria. Johanna I. Lutter's co-authors include Claus Vogelmeier, Rudolf A. Jörres, Kathrin Kahnert, Peter Alter, Larissa Schwarzkopf, Rolf Holle, Tobias Welte, Reiner Leidl, Franziska Trudzinski and Jürgen Behr and has published in prestigious journals such as Respiratory Medicine, Respiratory Research and Respiration.

In The Last Decade

Johanna I. Lutter

21 papers receiving 228 citations

Peers

Countries citing papers authored by Johanna I. Lutter

Since Specialization

Citations

This map shows the geographic impact of Johanna I. Lutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna I. Lutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna I. Lutter more than expected).

Fields of papers citing papers by Johanna I. Lutter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna I. Lutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna I. Lutter. The network helps show where Johanna I. Lutter may publish in the future.

Co-authorship network of co-authors of Johanna I. Lutter

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna I. Lutter. A scholar is included among the top collaborators of Johanna I. Lutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna I. Lutter. Johanna I. Lutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021 2024 ·Oncology Research and Treatment ·(unknown), Johanna I. Lutter, (unknown), (unknown), Fabienne Schochter, Andreas Fuchs, (unknown)	0
2	Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET 2021 ·ERJ Open Research ·Kathrin Kahnert, Johanna I. Lutter, Tobias Welte, Peter Alter, Jürgen Behr, Felix Herth, Hans‐Ulrich Kauczor, Sandra Söhler, Michael Pfeifer, Henrik Watz, Claus Vogelmeier, Robert Bals, Rudolf A. Jörres, Franziska Trudzinski	8
3	Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort 2021 ·Respiration ·(unknown), Rudolf A. Jörres, Johanna I. Lutter, Benjamin Waschki, Diego Kauffmann‐Guerrero, Peter Alter, Franziska Trudzinski, Felix Herth, Rolf Holle, Jürgen Behr, Robert Bals, Tobias Welte, Henrik Watz, Claus Vogelmeier, Kathrin Kahnert	5
4	Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities 2021 ·Clinical Research in Cardiology ·Franziska Trudzinski, Christina Kellerer, Rudolf A. Jörres, Peter Alter, Johanna I. Lutter, Frederik Trinkmann, Felix Herth, Marion Frankenberger, Henrik Watz, Claus Vogelmeier, Hans‐Ulrich Kauczor, Tobias Welte, Jürgen Behr, Robert Bals, Kathrin Kahnert	13
5	Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences 2021 ·International Journal of COPD ·Johanna I. Lutter, Rudolf A. Jörres, Franziska Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann‐Guerrero, Jürgen Behr, Rolf Holle, Claus Vogelmeier, Kathrin Kahnert	7
6	Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET 2021 ·Respiratory Research ·Christina Kellerer, Rudolf A. Jörres, Antonius Schneider, Peter Alter, Hans‐Ulrich Kauczor, Bertram J. Jobst, Jürgen Biederer, Robert Bals, Henrik Watz, Jürgen Behr, Diego Kauffmann‐Guerrero, Johanna I. Lutter, Alexander Hapfelmeier, H Magnussen, Franziska Trudzinski, Tobias Welte, Claus Vogelmeier, Kathrin Kahnert	13
7	Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data 2021 ·International Journal of COPD ·(unknown), Johanna I. Lutter, Larissa Schwarzkopf, (unknown), Anja Schramm, Claus Vogelmeier, Reiner Leidl	12
8	COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort 2021 ·Respiratory Medicine ·Christina Kellerer, Kathrin Kahnert, Franziska Trudzinski, Johanna I. Lutter, (unknown), (unknown), Henrik Watz, Robert Bals, Tobias Welte, Claus Vogelmeier, Rudolf A. Jörres, Peter Alter	15
9	Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities 2021 ·Franziska Trudzinski, Christina Kellerer, Rudolf A. Jörres, Peter Alter, Johanna I. Lutter, Frederik Trinkmann, Felix Herth, Marion Frankenberger, (unknown), Claus Vogelmeier, Hans‐Ulrich Kauczor, Tobias Welte, Jürgen Behr, Robert Bals, Kathrin Kahnert	2
10	<p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p> 2020 ·International Journal of COPD ·Johanna I. Lutter, Rudolf A. Jörres, Tobias Welte, Henrik Watz, Benjamin Waschki, Peter Alter, Franziska Trudzinski, (unknown), Jürgen Behr, Robert Bals, Michael Studnicka, Rolf Holle, Claus Vogelmeier, Kathrin Kahnert	15
11	Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort 2020 ·Respiratory Medicine ·Johanna I. Lutter, (unknown), Larissa Schwarzkopf, Rudolf A. Jörres, Michael Studnicka, Kathrin Kahnert, Stefan Karrasch, Burkhard Bewig, Claus Vogelmeier, Rolf Holle	12
12	The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET 2020 ·Respiratory Research ·Kathrin Kahnert, (unknown), (unknown), Peter Alter, Franziska Trudzinski, Robert Bals, Johanna I. Lutter, Hartmut Timmermann, Sandra Söhler, S. Förderreuther, Dennis Nowak, Henrik Watz, Benjamin Waschki, Jürgen Behr, Tobias Welte, Claus Vogelmeier, Rudolf A. Jörres	5
13	Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study 2020 ·Respiratory Medicine ·(unknown), Anja Schramm, Christoph Kurz, Larissa Schwarzkopf, Johanna I. Lutter, Manuel Huber, Reiner Leidl	7
14	Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort 2020 ·BMC Pulmonary Medicine ·(unknown), Johanna I. Lutter, Rudolf A. Jörres, Kathrin Kahnert, Larissa Schwarzkopf, Michael Studnicka, Stefan Karrasch, Holger Schulz, Claus Vogelmeier, Rolf Holle	16
15	Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study 2019 ·Respiratory Research ·(unknown), Anja Schramm, Larissa Schwarzkopf, Johanna I. Lutter, (unknown), Manuel Huber, Reiner Leidl	24
16	<p>Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET</p> 2019 ·International Journal of COPD ·(unknown), Johanna I. Lutter, Margarethe Wacker, Rudolf A. Jörres, (unknown), Stefan Karrasch, Holger Schulz, Claus Vogelmeier, Rolf Holle	24
17	Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study 2019 ·Respiratory Research ·(unknown), (unknown), Rudolf A. Jörres, Jürgen Behr, Peter Alter, Johanna I. Lutter, (unknown), Sandra Söhler, Tobias Welte, Henrik Watz, Claus Vogelmeier, Franziska Trudzinski, Winfried Rief, Britta Herbig, Kathrin Kahnert	18
18	The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort 2019 ·Respiratory Research ·(unknown), (unknown), Robert Perneczky, Claus Vogelmeier, Jürgen Behr, Diego Kauffmann‐Guerrero, Peter Alter, Franziska Trudzinski, Robert Bals, Christian Grohé, Sandra Söhler, Benjamin Waschki, Johanna I. Lutter, Tobias Welte, Rudolf A. Jörres, Kathrin Kahnert	16
19	<p>Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort</p> 2019 ·Patient Preference and Adherence ·(unknown), Rudolf A. Jörres, Sandra Söhler, Tobias Welte, Jürgen Behr, Joachim H. Ficker, Robert Bals, Henrik Watz, Johanna I. Lutter, (unknown), Frank Biertz, Peter Alter, Claus Vogelmeier, Kathrin Kahnert	7
20	Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study 2019 ·Health Economics Review ·Johanna I. Lutter, (unknown), Margarethe Wacker, Joachim Winter, (unknown), Annette Peters, Rolf Holle, Reiner Leidl	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact